icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Dinosaur-slaying asteroid metal can eradicate cancer, research suggests

Dinosaur-slaying asteroid metal can eradicate cancer, research suggests
Cancer cells can be destroyed using the same metal from the asteroid believed to have caused the dinosaurs’ extinction.

Research by the University of Warwick in the UK and Sun Yat-Sen University in China found the dense metal, iridium, can be used to kill cancer cells by directly targeting them and filling them with a deadly ‘version’ of oxygen.

A rare metal that is found in meteoroids, iridium has been discovered in large amounts within the Earth’s crust from 66 million years ago, prompting the theory that it came from the asteroid that caused the extinction of dinosaurs.

"The precious metal platinum is already used in more than 50 percent of cancer chemotherapies,” Professor Peter Sadler said in a press release. “The potential of other precious metals such as iridium to provide new targeted drugs which attack cancer cells in completely new ways and combat resistance, and which can be used safely with the minimum of side-effects, is now being explored.”

"It's certainly now time to try to make good medical use of the iridium delivered to us by an asteroid 66 million years ago," he added.

Scientists created a compound of iridium and organic metal to target cancer cells, which can transfer the energy inside the cell into a singlet oxygen, which is poisonous and kills the cell.

The iridium compound is introduced into the tumor and a laser is shone through the skin to the cancerous area to trigger the process. This hits the light-reacting coating of the compound and the metal then starts to fill the cell with singlet oxygen.

The researchers experimented with a model tumor of lung cancer cells. They targeted the tumor with a red laser, which activated the compound and penetrated and infused into the tumor’s different layers, killing it all.

They also tested the method by applying it to healthy cells, and found it had no effect on them.

The research showed the iridium compound damaged key molecules of the cells, the proteins for glucose metabolism and heat shock stress.

"This project is a leap forward in understanding how these new iridium-based anti-cancer compounds are attacking cancer cells, introducing different mechanisms of action, to get around the resistance issue and tackle cancer from a different angle," the study’s co-author Cookson Chiu said.

The research was published in the Wiley journal Angewandte Chemie.

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.